Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Current Assets: 2020-2025

Historic Current Assets for Arcutis Biotherapeutics (ARQT) over the last 6 years, with Sep 2025 value amounting to $349.2 million.

  • Arcutis Biotherapeutics' Current Assets fell 17.58% to $349.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $349.2 million, marking a year-over-year decrease of 17.58%. This contributed to the annual value of $335.8 million for FY2024, which is 1.63% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Current Assets is $349.2 million, which was up 4.94% from $332.8 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Current Assets ranged from a high of $496.7 million in Q3 2022 and a low of $281.5 million during Q3 2023.
  • In the last 3 years, Arcutis Biotherapeutics' Current Assets had a median value of $335.8 million in 2024 and averaged $359.7 million.
  • Its Current Assets has fluctuated over the past 5 years, first soared by 96.67% in 2021, then slumped by 43.32% in 2023.
  • Arcutis Biotherapeutics' Current Assets (Quarterly) stood at $402.8 million in 2021, then grew by 8.60% to $437.4 million in 2022, then fell by 24.46% to $330.4 million in 2023, then increased by 1.63% to $335.8 million in 2024, then fell by 17.58% to $349.2 million in 2025.
  • Its last three reported values are $349.2 million in Q3 2025, $332.8 million for Q2 2025, and $323.7 million during Q1 2025.